Filing Details
ULTRALIFE CORP (NASDAQ:ULBI) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
The Industrials company reported Q0 revenue of .
10q filedNASDAQ:ULBI
ULTRALIFE CORP (ULBI) Files Quarterly Report for Q0
ULTRALIFE CORP (NASDAQ:ULBI) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
At publication ·
What changed
ULTRALIFE CORP (NASDAQ:ULBI) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- ULTRALIFE CORP filed its quarterly report (Form 10-Q) with the SEC on August 07, 2026.
- The company's stock trades at $6.35 with a market capitalization of $95.9M.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this summary.
Market Context
ULTRALIFE CORP's stock currently trades at $6.35 with a market capitalization of $95.9M.
The 10-Q provides ULTRALIFE CORP's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for ULTRALIFE CORP are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ULBI Stock Page
Frequently Asked Questions
Where can I read ULBI's SEC filings?
Browse all filings on our ULBI SEC filings page.
What types of SEC filings does ULTRALIFE CORP file?
Public companies like ULTRALIFE CORP file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.